Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer

Figure 1 Expression and clinicopathological characteristics of peroxiredoxin 1 mRNA presented in The Cancer Genome Atlas liver cancer RNA sequencing dataset. A: Peroxiredoxin 1 (PRDX1) mRNA was significantly up-regulated in tumor tissues (n = 374) compared with the adjacent non-tumor tissues (n = 50); B: Kaplan-Meier curves of overall survival (left panel) and recurrence (right panel) according to the PRDX1 levels in tumor samples. Log-rank test was performed; C: The clinicopathological characteristics analysis of PRDX1 expression in 374 liver cancer cases. RPM: Read per Million; RPM: Read per Million; AFP: α-fetoprotein.